Today’s CSR movers
ETR 4.0 ▲ 1.5
SO 3.0 ▲ 1.0
NTAP 3.6 ▲ 0.5
PWR 4.6 ▲ 0.5
SNPS 4.6 ▲ 0.5
APA 3.1 ▲ 0.1
ITW 2.7 ▲ 0.1
CF 2.9 ▼ 0.1
VMC 3.7 ▼ 0.1
COO 3.6 ▼ 0.1
Health Care · NASDAQ NASDAQ · AMGN

Amgen

$377.35 -$5.06 -1.34% CLOSE 09.11.26 AFTER HOURS $378.21
Convergence score
3.1 / 5.0 NEUTRAL
+0.0 vs last report
Overall valuation
Fairly Valued
Aggregated across multiple horizons
Consensus target (12mo)
$386.14 +2.3%
Range $200.00 — $460.00
Sector
Health Care
NASDAQ · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 09.11.26
UV Convergence Score
REPORT 09.11.26
3.1
/ 5.0
NEUTRAL
Consensus signal A
3.0
Consensus signal B
3.0
Consensus signal D
3.0
Analyst average
3.4
Multi-signal aggregate How CSR works →
Day Range
$377.22 – $386.99
52W Range
$269.77 – $447.03
Volume
2.3M
Avg Vol
2.7M
Mkt Cap
$204.01B
P/E
23.44
EPS (TTM)
$16.10
Div Yield
2.64%
Beta
0.43
Today's convergence

Convergence score sits at 3.1 with overall valuation reading as fairly valued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Fairly Valued
CSR direction
NEUTRAL
Last close
$377.35
Sector
Health Care
Valuation
Three horizons
UPDATED 09.11.26
Short term
0–3 MO
No target
Medium term
3–12 MO
$382+1.1% Hold
Long term
12–36 MO
$360.30-4.5% Fairly Valued
Open valuation
Analysts
Coverage & consensus
5 PANELS
Mean target (12mo)
$386.14 +2.3%
RANGE $200.00 — $460.00
Analyst consensus
Consensus rating Hold
Blended score 3.1 / 5
Analysts tracked 165
Open analysts
Financials
Key metrics
LATEST
P/E
23.44
EPS (TTM)
$16.10
Mkt Cap
$204.01B
Div Yield
2.64%
Beta
0.43
52W Range
$269.77 – $447.03
Open financials
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in
Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26
Short term
0–3 MO
Consensus target
No target available
Medium term
3–12 MO
Hold
Consensus target
$382 +1.1%
RANGE $200 – $460
$200NOW $377.35$460

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Fairly Valued
Consensus target
$360.30 -4.5%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Analyst coverage

Blended analyst consensus & targets.

5 PANELS · UPDATED 09.11.26
Analyst consensus
Rating Blended score Panels Analysts
Hold 3.1 5 165
Price targets
Coverage Low Mean Median High Upside
All panels $200.00 $386.14 $395.00 $460.00 +2.3%
Rating distribution
Coverage SB B H S SS
All panels 5 19 33 5 2
Rating trend
Period Rating Avg Analysts
Current
1 Mo Ago
2 Mo Ago
3 Mo Ago
Most recent analyst action
Date
9/10/2026
Firm
HSBC
Action
Downgrade
Rating
Buy ➝ Hold
Target
$425.00
Financials

Full financial snapshot.

UPDATED 09.11.26
Quote snapshot
Prev Close
$382.47
Open
$386.99
Day Low
$377.22
Day High
$386.99
Bid
$382.95
Ask
$382.39
52W Low
$269.77
52W High
$447.03
50D Avg
$398.78
200D Avg
$359.17
Volume
2.3M
Avg Vol
2.7M
10D Avg Vol
2.7M
52W Change
38.38%
S&P 52W Change
15.30%
Valuation ratios
P/E (TTM)
23.44
P/E (Fwd)
15.46
PEG (Fwd)
1.88
P/S
5.36
P/B
17.45
Book Value
$21.62
EV/Revenue
6.49
EV/EBITDA
14.32
Mkt Cap
204.01B
Enterprise Val
247.32B
Profitability & returns
Profit Margin
22.95%
Gross Margin
71.89%
Operating Margin
35.55%
EBITDA Margin
45.33%
Return on Assets
8.67%
Return on Equity
91.47%
Growth
Revenue Growth (YoY)
9.50%
Earnings Growth (YoY)
64.90%
Earnings Growth (Q)
65.90%
Balance sheet & cash flow
Total Revenue
38.09B
EBITDA
17.27B
Total Cash
13.99B
Total Debt
57.3B
Cash / Share
$25.88
Revenue / Share
$70.68
Free Cash Flow
8.65B
Operating CF
12.48B
Debt / Equity
490.28
Current Ratio
1.37
Quick Ratio
0.95
Dividend
Fwd Dividend
10.08 (2.64%)
Dividend Yield
2.64%
Payout Ratio
60.87%
5Y Avg Yield
3.07%
Ex-Div Date
2026-08-21
Share statistics
Shares Out
540.63M
Float
539.16M
Shares Short
12.97M
% Short of Float
2.40%
Short Ratio
5.11
% Held Insiders
0.23%
% Held Institutions
85.01%
Calendar & events
Next Earnings
2026-11-03
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-06-30
Last Split
2:1
Split Date
1999-11-22
Company
Industry
Drug Manufacturers - General
Employees
31,500